|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.082 NZD | -2.38% |
|
-3.53% | -29.91% |
| Apr. 09 | Pacific Edge Reports Steady Growth in Bladder Cancer Test Volumes in Fiscal Q4 | MT |
| Mar. 14 | New Zealand Shares Flat on Thursday; Pacific Edge's Chair to Retire | MT |
Pacific Edge Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was NZD 19.62 million compared to NZD 11.45 million a year ago. Revenue was NZD 26.12 million compared to NZD 13.88 million a year ago.
Net loss was NZD 26.97 million compared to NZD 19.79 million a year ago. Basic loss per share from continuing operations was NZD 0.033 compared to NZD 0.026 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.91% | 39.47M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
PACIFIC EDGE LIMITED 
